Results 151 to 160 of about 338,947 (383)

Targeting JAK‐1 in Disseminated Cutaneous Lichen Planus

JEADV Clinical Practice, EarlyView.
ABSTRACT We report the case of a 63‐year‐old woman with an exuberant and recalcitrant clinical presentation of LP who had an excellent response to 200 mg/day abrocitinib, a JAK‐1 inhibitor, after failure to other commonly used therapies. The efficacy of JAK inhibitors in lichen planus is supported by small case series and isolated case reports. Further
F. Barbosa, L. Siems, D. Luz, A. Duarte
wiley   +1 more source

Optimising Vaccination Status in a Belgian Dermatological Immune‐Mediated Inflammatory Disease Population: An Education‐Based Pro‐Active Patient‐Centred Approach

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Patients with dermatological immune mediated inflammatory diseases (IMIDs) are increasingly treated with immunosuppressive and ‐modulating drugs. Some of these drugs increase the risk of acquiring infections and more complications can arise during an infection while treated with these agents.
Femke Lieten, Tine Vanhoutvin, Dorien Hunin, Céline Vanvelk, Liesbeth Gilissen, Petra De Haes, An Van Laethem, Francisca Castelijns, Tom Hillary   +8 more
wiley   +1 more source

Shrinkage estimation for dose-response modeling in phase II trials with multiple schedules

, 2020
Recently, phase II trials with multiple schedules (frequency of administrations) have become more popular, for instance in the development of treatments for atopic dermatitis.
Friede, Tim, Günhan, Burak Kürsad, Meyvisch, Paul   +2 more
core   +1 more source

A Nascent Nasal Phenomenon

JEADV Clinical Practice, EarlyView.
Amy Long, Claire Quigley, Lisa Murphy, Niamh Leonard, Julianne Clowry   +4 more
wiley   +1 more source

Causal association between atopic dermatitis and Parkinson's disease: A bidirectional Mendelian randomization study

Brain and Behavior
Background Atopic dermatitis is one of the most common skin disorders. Evidence has suggested an association between skin disorders, such as atopic dermatitis, and Parkinson's disease (PD).
Taofeng Zhou, Baohao Wei, Yachun Hu, Xiaoming Zhou, Xiaoying Cai, Xiaolei Shi   +5 more
doaj   +1 more source

Association of Short‐Term Wildfire Air Pollution Exposure and Health Care Usage: A Cross‐Sectional Study Among Patients With Psoriasis From the Bay Area, United States

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Wildfire air pollution causes many adverse environmental and health effects, including adverse skin reactions. However, whether wildfire‐associated air pollution and psoriasis disease activity are associated remains unknown. Objectives To examine the association between short‐term exposure to air pollution from wildfires and rates ...
Johan Anker Chrom Allerup, Somaia Naassan, Zarqa Ali, Justin M. Ko, Kenneth Thomsen, Simon Francis Thomsen   +5 more
wiley   +1 more source

Modern treatment methods in atopic dermatitis - literature overview

Journal of Education, Health and Sport
Introduction and aim: Atopic dermatitis (AD) is a chronic inflammatory skin disease. It is characterised by periods of exacerbation and remission of symptoms such as pruritus, dry skin and eczematous lesions with characteristic morphology.
Martyna Borowska-Łygan, Jakub Tomaszewski, Wojciech Urban, Konrad Strużek, Jan Biłogras, Kornelia Karamus, Rafał Wojciech Rejmak   +6 more
doaj   +1 more source

Superficial Pustular Folliculitis of the Face and Neck—A Non‐Infectious Eruption Responding to Topical Steroids

JEADV Clinical Practice, EarlyView.
Twenty‐seven young patients, mostly females, presenting with monomorphous, discrete, tiny, superficial follicular pustules on the face (44.4%), the face and neck (51.8%) and the neck (3.7%). The eruption was itchy in 44.4%, recurrent in 81% of cases and responded well to topical corticosteroids. Histopathologic findings of 3 cases revealed infundibular
Hui‐Peng Huang, Chang‐Ming Huang, Chao‐Kai Hsu, Chao‐Chun Yang, Julia Yu‐Yun Lee   +4 more
wiley   +1 more source

Successful Lebrikizumab Therapy in Two Patients With Atopic Dermatitis Resistant to Multiple Therapies

JEADV Clinical Practice, EarlyView.
ABSTRACT The treatment landscape for moderate‐to‐severe atopic dermatitis (AD) has evolved significantly with the introduction of novel targeted therapies addressing specific pathogenic mechanisms of the disease. Despite this therapeutic revolution, a proportion of patients experience intolerance and/or inadequate response to multiple lines of ...
Elena Ippoliti, Niccolò Gori, Benedetta Ambrosio, Giulia Coscarella, Maria Vittoria Cannizzaro, Ketty Peris   +5 more
wiley   +1 more source

Pilot Study of Tildrakizumab in the Treatment of Stable Non‐Segmental Vitiligo

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Treatment for vitiligo is limited, with variable efficacy, and can be time‐consuming or expensive. Recent developments within biologic therapy have demonstrated promising results with managing chronic autoimmune conditions. Objectives To evaluate the efficacy of tildrakizumab in inducing repigmentation in vitiligo.
Henry Lee, Timothy L. Cowan, Cheng Huang, Anna Wilson, Ben Koszegi, Corey Stone, Jade Ng, Sera Sarsam, Hossein Akbarialiabad, Joslin S. Johal, Oliver G. C. Murrell, Richard A. Wittal, Dédée F. Murrell, Benjamin S. Daniel   +13 more
wiley   +1 more source